News About the Dean

Looking Back, Moving Forward: Duke University School of Medicine 2024 Year in Review

From pursuing climate change research to enhancing the partnership with the Veteran's Administration, and advancing the groundbreaking FDA-approved drug for low-grade gliomas developed by the team at the Preston Robert Tisch Brain Tumor Center, the achievements at the Duke University School of Medicine in 2024 have been remarkable. Watch this short video that highlights these and other milestones.

Celebrating the Holiday Season Together

Join Dr. Klotman and her family as they share holiday cheer and reflect on the remarkable milestones achieved by our school this year. From groundbreaking research to impactful community partnerships, this festive message encourages everyone to prioritize health and well-being during the holiday season. Let's look forward to an even more successful 2025 together.

Advancing Health Policy: A Conversation with Dr. Mark McClellan

Mary Klotman, MD, talks with Dr. Mark McClellan, director of the Duke-Margolis Institute for Health Policy. They discuss the institute's mission to improve health care accessibility, affordability, and equity through evidence-based solutions, and explore its collaborative efforts with various organizations to advance health policy initiatives.

Mary E. Klotman's Friday Message and Updates

Dean Mary Klotman, MD, shares updates on significant research achievements, prestigious awards, and upcoming events. She also takes a moment to recognize National Native American Heritage Month and honor our veterans.

Mary E. Klotman's Friday Message and Updates

Duke University School of Medicine Dean Mary Klotman, MD, shares updates on significant research achievements, prestigious awards, upcoming events, and important health reminders.

Breakthroughs in Brain Tumor Treatment: A Conversation with Dr. David M. Ashley

Mary Klotman, MD, talks with David M. Ashley, MBBS, FRACP, PhD, MBBS (Hons), Director of the Preston Robert Tisch Brain Tumor Center at Duke. They discuss the challenges of treating brain tumors and recent advancements, including an FDA-approved drug for treating low-grade gliomas developed at the center, vorasidenib.

Mary E. Klotman's Friday Message and Updates

Dean Mary Klotman, MD, shares updates on welcoming new students, significant research achievements, prestigious awards, upcoming events, and important health reminders.

How Climate Change Affects Health: A Conversation with Robert Tighe, MD

Executive Vice President for Health Affairs and Dean of the Duke University School of Medicine Mary Klotman, MD, talks with Robert Tighe, MD, about the school’s new climate change research strategy, emphasizing the critical need to address the climate crisis and its impact on health.